Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and celecoxib

staurosporine has been researched along with celecoxib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assefnia, S; Brown, ML; Byers, SW; Dakshanamurthy, S; Issa, NT; Madhavan, S; Peters, OJ; Seshasayee, A; Uren, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Audo, R; Combe, B; Deschamps, V; Hahne, M; Morel, J1
Jeong, IH; Kim, YM; Pyo, H1

Other Studies

4 other study(ies) available for staurosporine and celecoxib

ArticleYear
Predicting new indications for approved drugs using a proteochemometric method.
    Journal of medicinal chemistry, 2012, Aug-09, Volume: 55, Issue:15

    Topics: Animals; Antineoplastic Agents; Antirheumatic Agents; Cadherins; Celecoxib; Cell Line, Tumor; Crystallography, X-Ray; Databases, Factual; Drug Discovery; Drug Repositioning; Drugs, Investigational; Human Umbilical Vein Endothelial Cells; Humans; Mebendazole; Mice; Models, Molecular; Neovascularization, Pathologic; Pharmaceutical Preparations; Protein Binding; Protein Conformation; Proteins; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor Receptor-2

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts.
    Arthritis research & therapy, 2007, Volume: 9, Issue:6

    Topics: Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Arthritis, Rheumatoid; Caspase 3; Celecoxib; Cell Death; Cell Proliferation; Cells, Cultured; Cyclooxygenase Inhibitors; Fibroblasts; Humans; Pyrazoles; Staurosporine; Sulfonamides; Synovial Membrane; TNF-Related Apoptosis-Inducing Ligand

2007
Celecoxib enhances the radiosensitizing effect of 7-hydroxystaurosporine (UCN-01) in human lung cancer cell lines.
    International journal of radiation oncology, biology, physics, 2012, Jul-01, Volume: 83, Issue:3

    Topics: Celecoxib; Cell Line, Tumor; Checkpoint Kinase 1; Cyclooxygenase 2 Inhibitors; Drug Synergism; Drug Therapy, Combination; G2 Phase; Humans; Mitosis; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Staurosporine; Sulfonamides; Tumor Stem Cell Assay

2012